Immune System News and Research

RSS

Gut microbiome could be used to predict individual's risk of bowel cancer

The makeup of the bacterial community that lives in the gut has been identified as a risk factor for bowel cancer.

10 Sep 2019

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Tel Aviv University and Sheba Medical Center researchers say they have discovered why more than half of patients with metastatic melanoma do not respond to immunotherapy cancer treatments.

10 Sep 2019

Rutgers study finds genetically tractable cause of drug-tolerant tuberculosis

A Rutgers New Jersey Medical School study has found a genetically tractable cause of drug tolerant tuberculosis, paving the way for researchers to develop new drugs to combat the global TB epidemic and cure the disease.

9 Sep 2019

Microbiome loss from antibiotic use affects response to flu vaccine

Every living person has trillions of microbes living in their digestive tract, and more than 400 species of bacteria in the gut, more than the number of cells in the body. The normal gut flora is important to maintain eubiosis, the microbial balance in the body.

9 Sep 2019

Drug tolerant Tuberculosis could soon be tracked using genes

A team of researchers from the Rutgers New Jersey Medical School have found genetic foot prints of tuberculosis bacteria that are resistant to the commonly used anti-tubercular drugs. This could help scientists develop drugs to combat drug resistance in tuberculosis.

8 Sep 2019

Oral antibiotics that kill gut microorganisms can alter immune response to flu vaccines

The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system. In a new paper published this week in Cell, researchers found that oral antibiotics, which can kill gut microorganisms, can alter the human immune response to seasonal influenza vaccination.

8 Sep 2019

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to unleash a patient's immune system to attack cancer, has been revolutionary in its implications for breast cancer treatment, especially for its potential to treat patients with triple negative breast cancer.

8 Sep 2019

Vaping-related respiratory illness characterized by lipid-laden macrophages in the lungs

Doctors have identified a previously unrecognized characteristic of the vaping-related respiratory illness that has been emerging in clusters across the U.S. in recent months.

8 Sep 2019

Researchers find synergistic connection between two deadly blood-clotting diseases

Two rare but potentially deadly blood-clotting diseases, namely thrombotic thrombocytopenic purpura, or TTP, and hemolytic uremic syndrome, or HUS, show similar pathologies -- a multitude of painful blockages in small blood vessels that cause varying degrees of organ injury throughout the body. However, the two disorders have distinct biological mechanisms.

8 Sep 2019

Study: One-third of children admitted in ICUs for sepsis show PTSD symptoms

Doctors have found that children who have been in Intensive Care Units (ICUs) for sepsis have a significantly increased risk of Post-Traumatic Stress Disorder (PTSD), with around 1/3 showing PTSD symptoms.

8 Sep 2019

ERC Starting Grant to support research on how gut bacteria may affect blood pressure

The community of bacteria inhabiting our bowels, known as the gut microbiome, affects our health and immune system - in a range of different ways.

7 Sep 2019

Tiny fat bubbles hold key to rebooting the immune system and calming disease process

People living with inflammatory autoimmune disease could benefit from an 'immune system reboot', and researchers have isolated specific cells to target.

7 Sep 2019

Vapor from e-cigarettes may impair the cells that line the lungs

Inhaling the vapor from e-cigarettes may cause cellular changes in the lungs that increase susceptibility to viruses, find scientists.

6 Sep 2019

Mesh electronics could make brain stimulation the new therapeutic norm

Implantable brain electrodes have been around for quite some time now, both for diagnosing and treating neuropsychiatric conditions like Parkinson’s disease. However, one limitation of conventional probes is their size and rigidity, compared to the soft, gelatinous consistency of the brain.

6 Sep 2019

All sodas including diet increase risk of premature death

Drinking carbonated drinks such as soft drinks, sodas and colas has long been dubbed as unhealthy, with all the added sugar they contain. Now, a new study added new information on the bad effects of soft drinks to the health.

6 Sep 2019

Cancer patients with low income and no insurance see fewer trial benefits

When it comes to benefiting from experimental treatments offered in cancer clinical trials, your health insurance status and where you live matters, according to results of two new research studies to be presented at the 2019 ASCO Quality Care Symposium, held September 6 and 7 in San Diego.

5 Sep 2019

Large-scale study maps the genetic underpinnings of early TB progression

While the vast majority of the 1.8 billion people infected with the TB bacterium never experience active disease, an estimated 5 to 15 percent do develop full-blown infections--roughly half of them within 18 months of exposure.

4 Sep 2019

Study reveals insights into new populations of immune cells in the lungs

Due to their function, the lungs are constantly exposed to various compounds carried in the air, sometimes harmful, sometimes harmless.

4 Sep 2019

$15 million grant funds new effort to develop universal vaccine for strep throat infections

CARB-X, an international non-profit partnership of private, academic and government institutions, has awarded SutroVax, Inc., a Northern California-based biopharmaceutical company, with an award of up to $15 million to develop a universal vaccine for Group A Streptococcus, the bacteria that causes pharyngitis or strep throat.

4 Sep 2019

Pneumonia uses hydrogen peroxide to weaken the immune system

Pneumonia is a lung infection, filling up the alveoli with pus and fluid. At present, it’s the leading cause of death among children. The lung infection accounts for 15 percent of all deaths in children below five years old, killing more than 800,000 children in 2017 alone.

3 Sep 2019

Immune System News and Research

Gut microbiome could be used to predict individual's risk of bowel cancer

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Rutgers study finds genetically tractable cause of drug-tolerant tuberculosis

Microbiome loss from antibiotic use affects response to flu vaccine

Drug tolerant Tuberculosis could soon be tracked using genes

Oral antibiotics that kill gut microorganisms can alter immune response to flu vaccines

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Vaping-related respiratory illness characterized by lipid-laden macrophages in the lungs

Researchers find synergistic connection between two deadly blood-clotting diseases

Study: One-third of children admitted in ICUs for sepsis show PTSD symptoms

ERC Starting Grant to support research on how gut bacteria may affect blood pressure

Tiny fat bubbles hold key to rebooting the immune system and calming disease process

Vapor from e-cigarettes may impair the cells that line the lungs

Mesh electronics could make brain stimulation the new therapeutic norm

All sodas including diet increase risk of premature death

Cancer patients with low income and no insurance see fewer trial benefits

Large-scale study maps the genetic underpinnings of early TB progression

Study reveals insights into new populations of immune cells in the lungs

$15 million grant funds new effort to develop universal vaccine for strep throat infections

Pneumonia uses hydrogen peroxide to weaken the immune system

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News